Efficacy of Lorlatinib in Treatment-Naive Patients (pts) With ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in Relation to EML4-ALK Variant Type and ALK Mutations
Journal article published in 2021 by
Alessandra Bearz,
Jean-Francois Martini,
Jacek Jassem,
Sang-We Kim,
Gee-Chen Chang,
Alice Shaw,
Deborah Shepard,
Elisa Dall'O',
Anna Polli,
Holger Thurm,
Gerard Zalcman 
,
Maria Rosario Garcia Campelo,
Konstantin Penkov,
Hidetoshi Hayashi,
Benjamin J. Solomon
,
Maria Rosario Garcia Campelo,
Konstantin Penkov,
Hidetoshi Hayashi,
Benjamin J. Solomon
